Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination

GLIA

Volumn 28, Issue 1, 1999, Pages 77-83

  Shields, Simon A ^a   Gilson, Jennifer M ^a   Blakemore, William F ^a   Franklin, Robin J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Ageing; Ethidium bromide; Lysolecithin; Regeneration

Indexed keywords

ETHIDIUM; FLUORESCENT DYE; GLIOTOXIN; IMMUNOSUPPRESSIVE AGENT; LYSOPHOSPHATIDYLCHOLINE;

AGING; ANIMAL; ARTICLE; CEREBELLUM NUCLEUS; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DEMYELINATING DISEASE; FEMALE; KINETICS; MYELIN SHEATH; PATHOLOGY; PHYSIOLOGY; RAT; SPINAL CORD; SPRAGUE DAWLEY RAT;

AGING; ANIMALS; CEREBELLAR NUCLEI; DEMYELINATING DISEASES; ETHIDIUM; FEMALE; FLUORESCENT DYES; GLIOTOXIN; IMMUNOSUPPRESSIVE AGENTS; KINETICS; LYSOPHOSPHATIDYLCHOLINES; MYELIN SHEATH; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0033215282     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F     Document Type: Article

References (27)

1. Archer DR, Cuddon PA, Lipsitz D, Duncan ID. 1997. Myelination of the canine central nervous system by glial cell transplantation: a model for repair of human myelin disease. Nature Med 3:54-59.
2. Blakemore WF. 1973. Remyelination of the superior cerebellar peduncle in old mice following demyelination induced by cuprizone. J Neurol Sci 22:121-126.
3. Blakemore WF. 1978. Observations on remyelination in the rabbit spinal cord following demyelination induced by lysolecithin. Neuropathol Appl Neurobiol 4:47-59.
4. Blakemore W, Franklin RJM. 1999. Transplantation options for therapeutic CNS remyelination. Cell Transplant (in press).
5. Blakemore WF, Crang AJ, Franklin RJM, Tang K, Ryder S. 1995. Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS. Glia 13:79-91.
6. Carroll WM, Jennings AR. 1994. Early recruitment of oligodendrocyte precursors in CNS remyelination. Brain 117:563-578.
7. Duncan ID, Grever WE, Zhang SC. 1997. Repair of myelin disease: strategies and progress in animal models. Mol Med Today 3:554-561.
8. Franklin RJM, Gilson JM, Blakemore WF. 1997. Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. J Neurosci Res 50:337-344.
9. Gilson J, Blakemore WF. 1993. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol 19:173-181.
10. Graça DL, Blakemore WF. 1986. Delayed remyelination in the rat spinal cord following ethidium bromide injection. Neuropathol Appl Neurobiol 12:593-605.
11. Jeffery ND, Blakemore WF. 1995. Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol 24:775-781.
12. Jones SJ. 1993. Visual evoked potentials after optic neuritis. Effect of time interval, age and disease dissemination. J Neurol 240:489-494.
13. Keirstead HS, Levine JM, Blakemore WF. 1998. Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22:161-170.
14. Komoly S, Hudson LD, Webster HD, Bondy CA. 1992. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. Proc Natl Acad Sci USA 89:1894-1898.
15. Kriss A, Francis DA, Cuendet F, Halliday AM, Taylor DS, Wilson J, Keast-Butler J, Batchelor JR, McDonald WI. 1988. Recovery after optic neuritis in childhood. J Neurol Neurosurg Psychiatr 51:1253-1258.
16. Ludwin SK. 1980. Chronic demyelination inhibits remyelination in the central nervous system. Lab Invest 43:382-387.
17. McKay JS, Blakemore WF, Franklin RJM. 1997. The effects of the growth factor-antagonist, trapidil, on remyelination in the CNS. Neuropathol Appl Neurobiol 23:50-58.
18. McKay JS, Blakemore WF, Franklin RJM. 1998. Trapidil-mediated growth factor-inhibition during CNS remyelination results in reduced numbers of oligodendrocytes. Neuropathol Appl Neurobiol 24:498-506.
19. Miller DJ, Asakura K, Rodriguez M. 1996. Central nervous system remyelination clinical application of basic neuroscience principles. Brain Pathol 6:331-344.
20. Nait Oumesmar B, Vignais L, Duhamel-Clérin E, Avellana-Adalid V, Rougon G, Baron-Van Evercooren A. 1995. Expression of the highly polysialylated neural cell adhesion molecule during postnatal myelination and following chemically induced demyelination of the adult mouse spinal cord. Eur J Neurosci 7:480-491.
21. O'Leary MT, Blakemore WF. 1997. Use of a rat Y chromosome probe to determine the long-term survival of glial cells transplanted into areas of CNS demyelination. J Neurocytol 26:191-206.
22. Pavelko KD, Van Engelen BGM, Rodriguez M. 1998. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J Neurosci 18:2498-2505.
23. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. San Diego: Academic Press.
24. Tourbah A, Baron van Evercooren A, Oliver L, Raulais D, Jeanny JC, Gumpel M. 1992. Endogenous aFGF expression and cellular changes after a demyelinating lesion in the spinal cord of adult normal mice: immunohistochemical study. J Neurosci Res 33:47-59.
25. Triarhou LC, Herndon RM. 1986. The effect of dexamethasone on L-α-lysophosphatidyl choline (lysolecithin)-induced demyelination of the rat spinal cord. Arch Neurol 43:121-125.
26. Woodruff RH, Franklin RJM. 1999a. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide and complement/anti-galactocerebroside - a comparative study. Glia 25:216-228.
27. Woodruff RH, Franklin RJM. 1999b. The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination. Neuropathol Appl Neurobiol 25:226-235.